#FutureReadyHealthcare
Improved patient adherence for a global pharma’s specialty brands
Challenges
60% non-adherence to prescribed therapy by patients for specialty brands, resulting in revenue losses and gaps in achieving better health outcomes
No access to prescription/patient data to optimize and create better interventions
The Solution
We launched a first-of-its-kind patient support program (PSP) by integrating a call center, field councilors, and centralized CRM called Optimax™ to ensure optimized patient support across brands.On enrolling to the PSP, the patients can access benefits such as awareness & education, disease management, access to diagnostic labs & e-pharmacy, insurance, and micro finance, to aid affordability, improve adherence and health outcomes.
Leveraging patient, prescription and therapy data through Optimax™ helps better understand patient behavior, analyze drop-out reasons, and create further intervention plans.
Outcomes
The client is able to execute year-on-year renewals of PSP services for 32 brands, 7 therapy areas and enrolment of 300,000 patients successfully.It is now possible for the client to achieve an enrollment rate of 95%, adherence rate of 85%, compliance rate of 80% and process adherence of 90% across all patient support programs .
The quickly deployable plug and play model, initiating PSP across any therapy areas, helps fulfill commitments to be patient centric and future ready in delivering better products.
95%
Patient enrollment rate
90%
Process adherence across programs
80%
Therapy compliance
